Dramatic erythroid response to low-dose thalidomide in two patients with transfusion independent thalassemia and severe post-transfusional alloimmune hemolysis

Am J Hematol. 2015 Jul;90(7):E141. doi: 10.1002/ajh.24030.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anemia, Hemolytic / blood
  • Anemia, Hemolytic / drug therapy*
  • Anemia, Hemolytic / immunology
  • Anemia, Hemolytic / pathology
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Blood Transfusion
  • Female
  • Hemolysis / drug effects
  • Humans
  • Immunoglobulin Allotypes / blood
  • Immunologic Factors / therapeutic use
  • Immunosuppressive Agents / therapeutic use*
  • Middle Aged
  • Rituximab
  • Thalassemia / blood
  • Thalassemia / drug therapy*
  • Thalassemia / immunology
  • Thalassemia / pathology
  • Thalidomide / therapeutic use*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunoglobulin Allotypes
  • Immunologic Factors
  • Immunosuppressive Agents
  • Rituximab
  • Thalidomide